periodontitis, chronic inflammatory disease
Conditions
Interventions
Group 1: Observational study: patients suffering from chronic inflammatory diseases and receiving anti-cytokine therapy for the first time.
Sponsors
Innere Medizin I, UKSH Kiel
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Diagnosed chronic inflammatory disease - First-time targeted anti-cytokine therapy upcoming - Participation in the Biological Follow Up Study - Written informed consent
Exclusion criteria
Exclusion criteria: - Edentulousness - Ongoing periodontal therapy - Need for endocarditis prophylaxis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of periodontal parameters (BOP, sulcus depths) | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in the oral microbiome (diversities, bacterial composition) | — |
Countries
Germany
Contacts
Public ContactStefan Schreiber
Innere Medizin I
Outcome results
None listed